Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Xigen S.A.
DescriptionJNK inhibitor peptide
Molecular Target c-jun N-terminal kinase (JNK)
Mechanism of Actionc-jun N-terminal kinase (JNK) inhibitor
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard IndicationDry eye
Indication DetailsTreat dry eye
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today